BACKGROUND: The prevalence of Trichomonas vaginalis infection is highest in women with intermediate Nugent scores. We hypothesized that the vaginal microbiota in T. vaginalis-infected women differs from that in T. vaginalis-uninfected women. METHODS: Vaginal samples from 30 T. vaginalis-infected women were matched by Nugent score to those from 30 T. vaginalis-uninfected women. Equal numbers of women with Nugent scores categorized as normal, intermediate, and bacterial vaginosis were included. The vaginal microbiota was assessed using 454 pyrosequencing analysis of polymerase chain reaction-amplified 16S ribosomal RNA gene sequences. The 16S ribosomal RNA gene sequence of an unknown organism was obtained by universal bacterial polymerase chain reaction amplification, cloning, and sequencing. RESULTS: Principal coordinates analysis of the pyrosequencing data showed divergence of the vaginal microbiota in T. vaginalis-infected and T. vaginalis-uninfected patients among women with normal and those with intermediate Nugent scores but not among women with bacterial vaginosis. Cluster analysis revealed 2 unique groups of T. vaginalis-infected women. One had high abundance of Mycoplasma hominis and other had high abundance of an unknown Mycoplasma species. Women in the former group had clinical evidence of enhanced vaginal inflammation. CONCLUSIONS: T. vaginalis may alter the vaginal microbiota in a manner that is favorable to its survival and/or transmissibility. An unknown Mycoplasma species plays a role in some of these transformations. In other cases, these changes may result in a heightened host inflammatory response.
BACKGROUND: The prevalence of Trichomonas vaginalis infection is highest in women with intermediate Nugent scores. We hypothesized that the vaginal microbiota in T. vaginalis-infected women differs from that in T. vaginalis-uninfected women. METHODS: Vaginal samples from 30 T. vaginalis-infected women were matched by Nugent score to those from 30 T. vaginalis-uninfected women. Equal numbers of women with Nugent scores categorized as normal, intermediate, and bacterial vaginosis were included. The vaginal microbiota was assessed using 454 pyrosequencing analysis of polymerase chain reaction-amplified 16S ribosomal RNA gene sequences. The 16S ribosomal RNA gene sequence of an unknown organism was obtained by universal bacterial polymerase chain reaction amplification, cloning, and sequencing. RESULTS: Principal coordinates analysis of the pyrosequencing data showed divergence of the vaginal microbiota in T. vaginalis-infected and T. vaginalis-uninfected patients among women with normal and those with intermediate Nugent scores but not among women with bacterial vaginosis. Cluster analysis revealed 2 unique groups of T. vaginalis-infected women. One had high abundance of Mycoplasma hominis and other had high abundance of an unknownMycoplasma species. Women in the former group had clinical evidence of enhanced vaginal inflammation. CONCLUSIONS:T. vaginalis may alter the vaginal microbiota in a manner that is favorable to its survival and/or transmissibility. An unknownMycoplasma species plays a role in some of these transformations. In other cases, these changes may result in a heightened host inflammatory response.
Authors: M Laga; A Manoka; M Kivuvu; B Malele; M Tuliza; N Nzila; J Goeman; F Behets; V Batter; M Alary Journal: AIDS Date: 1993-01 Impact factor: 4.177
Authors: M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads Journal: Sex Transm Dis Date: 1997-07 Impact factor: 2.830
Authors: H Minkoff; A N Grunebaum; R H Schwarz; J Feldman; M Cummings; W Crombleholme; L Clark; G Pringle; W M McCormack Journal: Am J Obstet Gynecol Date: 1984-12-15 Impact factor: 8.661
Authors: William L Smith; Spencer R Hedges; Eli Mordechai; Martin E Adelson; Jason P Trama; Scott E Gygax; Andrew M Kaunitz; David W Hilbert Journal: J Clin Microbiol Date: 2014-06-04 Impact factor: 5.948
Authors: Benjamin J Callahan; Daniel B DiGiulio; Daniela S Aliaga Goltsman; Christine L Sun; Elizabeth K Costello; Pratheepa Jeganathan; Joseph R Biggio; Ronald J Wong; Maurice L Druzin; Gary M Shaw; David K Stevenson; Susan P Holmes; David A Relman Journal: Proc Natl Acad Sci U S A Date: 2017-08-28 Impact factor: 11.205
Authors: Olamide D Jarrett; Sujatha Srinivasan; Barbra A Richardson; Tina Fiedler; Jacqueline M Wallis; John Kinuthia; Walter Jaoko; Kishor Mandaliya; David N Fredricks; R Scott McClelland Journal: J Infect Dis Date: 2019-09-26 Impact factor: 5.226
Authors: Melissa D Conrad; Patricia Kissinger; Norine Schmidt; David H Martin; Jane M Carlton Journal: Sex Transm Infect Date: 2013-05-21 Impact factor: 3.519
Authors: Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski Journal: Clin Infect Dis Date: 2015-12-15 Impact factor: 9.079